David Clark, DDS
Dr. David Clark is the director of Bioclear Learning Centers International. He holds 36 patents internationally integral to the Bioclear Method and Bioclear Matrix System. Dr. Clark has developed the Bioclear Matrix System that promises a real advancement for placement of biologically appropriate, esthetically pleasing direct composite restorations for treating minimally invasive Class II preparations, diastema closure, and black triangle elimination combined with papilla regeneration, and traditional anterior composites.
He is a 1986 graduate of the University of Washington School of Dentistry and maintains a private practice in Tacoma, WA.
Featured In-Person Courses
Destination CE
CRD destination courses are a fantastic opportunity for dental professionals to connect with industry-leading speakers, colleagues and friends to learn, network and share ideas. Take a trip with Dentistry's top key opinion leaders to experience the best dental CE that always keeps the patient's best outcomes in mind.
Online CE
CRD is committed to supporting dental professionals with access to online courses that fit their schedule, educational needs and interests. Experience the convenience of quality online continuing dental education that features Dentistry's top key opinion leaders in live-streamed and on-demand formats.
In-Office CE
Bring group training directly to your office! Mini Clinics are free, high-energy, interactive in-office sessions with your CRD Clinical Advisor. Mini Clinic courses provide you and your staff a refresher on dental best practices, techniques and procedures. You'll earn 1 CE credit per topic in the convenience of your office.
Clinical Research Dental/Clinician’s Choice is an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by the AGD for Fellowship/Mastership and Membership Maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from 1/1/2023 to 12/31/2026 and the Provider ID # is 208086.